Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
517.40
Change Change %
2.30 0.45%

Updated:16 Nov, 2018, 14:24 PM IST

BSE
516.90
Change Change %
1.95 0.38%

Updated:16 Nov, 2018, 14:52 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Nomura
N/A
08-12-2015 Hold 775.00 817.00
N/A
Target Hit Custom
08-12-2016

Nomura upgrades Sun Pharma to neutral

Gleevec approval is in-line with expectation. Failure to scale speciality business presents a downside risk to long-term growth assumptions, hence valuation multiples. Regulatory update on Halol facility and realisation of Ranbaxy synergy are the key catalysts for the stock.

Top